Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
334.088433678
InChI
InChI=1S/C17H16ClFN2O2/c18-12-5-3-11(4-6-12)17(21-9-1-2-16(20)23)14-10-13(19)7-8-15(14)22/h3-8,10,21H,1-2,9H2,(H2,20,23)/b17-14+
InChI Key
InChIKey=DWEQWXSKOHHBNT-SAPNQHFASA-N
IUPAC Name
4-{[(4-chlorophenyl)[(1E)-3-fluoro-6-oxocyclohexa-2,4-dien-1-ylidene]methyl]amino}butanamide
Traditional IUPAC Name
progabide
SMILES
NC(=O)CCCN\C(C1=CC=C(Cl)C=C1)=C1/C=C(F)C=CC1=O
pKa (strongest acidic)
15.32
pKa (Strongest Basic)
4.01
Refractivity
91.22 m3·mol-1
Dược Lực Học :
Progabide, a fatty acid derivative, is a GABA receptor agonist used to treat the symptoms of epilepsy.
Cơ Chế Tác Dụng :
Progabide is an analog and prodrug of gamma-aminobutyric acid. It is commonly used in the treatment of epilepsy. It has agonistic activity for both the GABAA and GABAB receptors. Progabide has been investigated for many diseases besides epilepsy, including Parkinson's disease, schizophrenia, clinical depression and anxiety disorder with varying success.
Progabide binds to both GABAA and GABAB receptors located on the terminals of primary afferent fibers. Binding to GABAA results in an increased affinity of the GABA receptor for the amino acid, an augmented flux of chloride ions across the terminal membrane, and an increase in the amount of presynaptic inhibition. Activation of the GABAB receptors retards the influx of calcium ions into the terminals, thereby reducing the evoked release of excitatory amino acids and possibly other transmitters.
Dược Động Học :
▧ Absorption :
Well absorbed with a bioavailability of 60%
▧ Protein binding :
95%
▧ Metabolism :
Hepatic
▧ Half Life :
4 hours
Chỉ Định :
Indicated for the treatment of epilepsy.